Flip on a college football game and count the commercial breaks before you see a GLP-1 ad. You won't get far. Between Ozempic, Wegovy, Zepbound, and the alphabet soup of telehealth brands (Ro, Hims, Hers), these drugs went from obscure diabetes medication to mainstream cultural phenomenon in about four years.
Here's the thing: the hype is, for once, mostly justified. Dr. Eric Trexler, RP Strength's resident research scientist, doesn't throw around the word "miraculous" lightly. But after reviewing the trial data and comparing it against a century of failed weight-loss drugs, he's willing to say it. Not because he's selling anything—he has zero financial relationship with any pharmaceutical company—but because the numbers are genuinely unprecedented.
Two parts of the story aren't on any billboard: oral versions are coming, and most people don't stay on these drugs for long. This post breaks down what the research actually shows—how they work, what happens in your body when you stop, and where the caveats sit.
How Do GLP-1, GIP, and Glucagon Drugs Actually Differ?
The drug names get confusing fast, so here's the breakdown in plain terms.
Semaglutide: The Single Agonist
Your body naturally produces GLP-1, a hormone involved in appetite regulation. Problem is, it has a short half-life—it does its job and disappears. Semaglutide is a synthetic GLP-1 receptor agonist engineered to stick around much longer, creating a sustained appetite-suppressing effect instead of a brief hormonal blip.
Tirzepatide: The Dual Agonist
Tirzepatide binds to GLP-1 receptors and GIP receptors—a second hormone pathway. That extra mechanism is why trial results consistently land higher than semaglutide alone.
Retatrutide: The Triple Agonist
Retatrutide adds a third mechanism: glucagon receptor agonism. Glucagon and insulin are locked in a constant tug-of-war over glucose metabolism, and the glucagon component appears to modestly increase metabolic rate on top of the appetite effects. This isn't just turning up the dial on an existing mechanism—it's bolting on a new one.
What Are the Real Side Effects of GLP-1 Drugs?
No drug is side-effect-free, and pretending otherwise would be dishonest. Here's what the data and anecdotal reports actually show.
Serious side effects exist and shouldn't be waved off. Reports include severe GI tract paralysis and, in rare cases, vision loss. Uncommon—but worth discussing with a clinician before starting.
Why Are Oral GLP-1 Versions Such a Big Deal?
It's not about the needles, although plenty of people are genuinely uncomfortable self-injecting. The bigger issue is logistics.
- Requires cold-chain shipping
- Requires refrigerated storage
- Expensive, and limits access outside wealthy countries
- Slightly larger weight loss effect in current data
- Shelf-stored, shipped like any standard pill
- Orforglipron, VK2735, amicretin, plus oral semaglutide
- Similar side effect profile
- Slightly smaller effect in early trials
The real impact won't be clinical. It'll be economic. Easier manufacturing and distribution should drive costs down significantly, and that matters a lot given that insurance coverage and out-of-pocket costs are currently the single biggest barrier to long-term use.
What Happens When You Stop Taking GLP-1 Drugs?
This is the question that should temper some of the enthusiasm, and it's backed by hard numbers.
A meta-regression put that regain on track to return people to baseline within about 18 months.
If the plan is "use it temporarily, then maintain the loss through willpower," the data doesn't back that up.
There's a plausible psychological argument that it's easier to adopt healthy habits starting from a lower body weight than from a higher one. But physiologically, pulling a tool this effective out of the equation creates serious headwinds.
Are There Benefits to GLP-1s Beyond Weight Loss?
Yes, and some appear independent of the weight loss itself.
FAQ: Common Questions About GLP-1 Weight Loss Drugs
Is semaglutide or tirzepatide better for weight loss?
Do GLP-1 drugs cause muscle loss?
Will I regain weight if I stop taking GLP-1 drugs?
Are oral GLP-1 drugs as effective as injections?
Can GLP-1 drugs help with food cravings and "food noise"?
What's the difference between GLP-1, GIP, and glucagon receptor agonists?
The Bottom Line
GLP-1 drugs represent a genuine inflection point in obesity treatment—not marketing spin, but a measurable shift in what's physiologically achievable. The caveats are real: cost, access, discontinuation rates, and side effects that range from annoying to rare-but-serious. None of that cancels out the scale of the breakthrough.
Anyone considering these medications should work with a clinician who's willing to individualize dosing rather than push a generic escalation schedule, pair treatment with resistance training and adequate protein, and go in with realistic expectations about what happens if or when they stop.
